Geriatric

Risk of Dementia

Prevention of AD: What the Lipidologist Needs to Know

Case Study: Statin Use in the Elderly: An Age-Old Question

Many physicians are faced with a growing elderly population in their practice and the resulting therapeutic dilemmas. A 10- year…

Age-Related Pharmacokinetic Changes and the Impact on Statin Therapy in Older Patients

While there is evidence for atherosclerotic cardiovascular risk reduction with statins in both primary and secondary prevention in older patients,…

The Use of Statins to Reduce Cardiovascular Risk in the Elderly

There is compelling and consistent evidence from clinical outcome trials that reducing the level of LDL-C with statins reduces the…

Risk Factors and Lifestyle Considerations in Older Adults

Age is the single biggest risk factor for cardiovascular disease (CVD) and, not surprisingly, age is associated with other risk…

Treating Hypercholesterolemia in Patients Aged 75 and Older Without Established Atherosclerotic Cardiovascular Disease

S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years and Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS

Listen to Dr. Brown discuss with Dr. Saseen the Scientific Statement from the NLA and the AGS on managing hypercholesterolemia…

Managing Hypercholesterolemia in Adults Older Than 75 Years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society

Statins reduce ASCVD events in adults older than75 years without prior ASCVD.

When Is It Reasonable to Consider Withholding Lipid Lowering Therapy?

Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth…